Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/55787
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3460]
Metadata
Show full item record
HUMAN SPOROTRICHOSIS: RECOMMENDATIONS FROM THE BRAZILIAN SOCIETY OF DERMATOLOGY FOR THE CLINICAL, DIAGNOSTIC AND THERAPEUTIC MANAGEMENT
Author
Orofino-Costa, Rosane
Freitas, Dayvison Francis Saraiva
Bernardes-Engemann, Andréa Reis
Rodrigues, Anderson Messias
Talhari, Carolina
Ferraz, Claudia Elise
Veasey, John Verrinder
Quintella, Leonardo
Sousa, Maria Silvia Laborne Alves de
Vettorato, Rodrigo
Almeida-Paes, Rodrigo de
Macedo, Priscila Marques de
Freitas, Dayvison Francis Saraiva
Bernardes-Engemann, Andréa Reis
Rodrigues, Anderson Messias
Talhari, Carolina
Ferraz, Claudia Elise
Veasey, John Verrinder
Quintella, Leonardo
Sousa, Maria Silvia Laborne Alves de
Vettorato, Rodrigo
Almeida-Paes, Rodrigo de
Macedo, Priscila Marques de
Affilliation
University of Rio de Janeiro State. Dermatology Department. Rio de Janeiro, RJ, Brazil / Brazilian Society of Dermatology. Department of Mycology. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / University of Rio de Janeiro State. Dermatology Department. Rio de Janeiro, RJ, Brazil.
Federal University of São Paulo. Discipline of Cell Biology. São Paulo, SP, Brazil.
University of Amazon State. Health School. Manaus, AM, Brazil.
Federal University of Pernambuco. Health Science Center. Recife, PE, Brazil.
Brazilian Society of Dermatology. Department of Mycology. Rio de Janeiro, RJ, Brazil / Santa Casa de Misericórdia. Faculty of Medical Sciences. São Paulo, SP, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Santa Casa de Misericórdia. Dermatology Clinic. Belo Horizonte, MG, Brazil.
Santa Casa de Misericórdia. Department of Dermatology. Porto Alegre, RS, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Brazilian Society of Dermatology. Department of Mycology. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / University of Rio de Janeiro State. Dermatology Department. Rio de Janeiro, RJ, Brazil.
Federal University of São Paulo. Discipline of Cell Biology. São Paulo, SP, Brazil.
University of Amazon State. Health School. Manaus, AM, Brazil.
Federal University of Pernambuco. Health Science Center. Recife, PE, Brazil.
Brazilian Society of Dermatology. Department of Mycology. Rio de Janeiro, RJ, Brazil / Santa Casa de Misericórdia. Faculty of Medical Sciences. São Paulo, SP, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Santa Casa de Misericórdia. Dermatology Clinic. Belo Horizonte, MG, Brazil.
Santa Casa de Misericórdia. Department of Dermatology. Porto Alegre, RS, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Brazilian Society of Dermatology. Department of Mycology. Rio de Janeiro, RJ, Brazil.
Abstract
Background: The increase in the zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis, which started in the late 1990s in Rio de Janeiro and is now found in almost all Brazilian states, has been equally advancing in neighboring countries of Brazil. Changes in the clinical-epidemiological profile, advances in the laboratory diagnosis of the disease, and therapeutic difficulties have been observed throughout these almost 25 years of the epidemic, although there is no national consensus. The last international guideline dates from 2007.
Objectives: Update the clinical classification, diagnostic methods and recommendations on the therapeutic management of patients with sporotrichosis.
Methods: Twelve experts in human sporotrichosis were selected from different Brazilian regions, and divided into three work groups: clinical, diagnosis and treatment. The bibliographic research was carried out on the EBSCOHost platform. Meetings took place via electronic mail and remote/face-to-face and hybrid settings, resulting in a questionnaire which pointed out 13 divergences, resolved based on the opinion of the majority of the participants.
Results: The clinical classification and laboratory diagnosis were updated. Therapeutic recommendations were made for the different clinical forms.
Conclusion: Publication of the first national recommendation, carried out by the Brazilian Society of Dermatology, aimed at the Brazilian scientific community, especially dermatologists, infectologists, pediatricians, family medicine personnel, and laboratory professionals who work in the management of human sporotrichosis.
Share